PharmGKB Blog
Friday, July 29, 2022

PharmVar GeneFocus paper for SLCO1B1 is published

›
The PharmVar GeneFocus:  SLCO1B1  paper has just been published by  Clinical Pharmacology & Therapeutics .   Th is   review   provides a...
Friday, July 22, 2022

CYP2A6 now released on PharmVar

›
PharmVar and PharmGKB are excited to share that   CYP2A6   has been transitioned into the PharmVar database. CYP2A6   metabolizes several su...
Tuesday, June 21, 2022

Clinical Genomics Career Panel webinar series 2022

›
ClinGen is hosting a Clinical Genomics Career Panel webinar series this summer for individuals interested in career in clinical genomics. S...

PharmGKB Acyclovir/Ganciclovir Pathway Published

›
The PharmGKB Acyclovir/Ganciclovir Pathway has recently been published in the journal Pharmacogenetics and Genomics . Acyclovir (ACV) and ga...
Thursday, June 2, 2022

Expansion of pharmacogenetics education agreed as part of lawsuit settlement

›
Oregon Health & Science University (OHSU) will introduce new educational initiatives on the risks of prescribing the chemotherapy drug c...
Thursday, May 19, 2022

Update to PharmGKB Pediatric Summaries - BPCA Drugs

›
The latest round of PharmGKB’s pediatric drug summaries is now live on  PharmGKB pediatric . This release includes summaries for 55 drugs, b...
Monday, May 16, 2022

Response to the American Academy of Pediatrics' Statement "Eliminating Race-Based Medicine"

›
On May 2nd, the American Academy of Pediatrics (AAP) released a pre-published policy statement titled “Eliminating Race-Based Medicine,” not...
‹
›
Home
View web version

Contributors

  • Caroline Thorn, Curator
  • Katrin Sangkuhl
  • Li Gong
  • Mark Woon
  • Mark Woon
  • Michelle Whirl-Carrillo, Director and Co-PI
  • Ryan Whaley, Technical Lead
  • Teri Klein, Co-PI PharmGKB, CPIC, PharmCAT & ClinGen
Powered by Blogger.